Relmada Therapeutics
RLMD
RLMD
50 hedge funds and large institutions have $3.18M invested in Relmada Therapeutics in 2025 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
+6
Holders Change %
+13.64%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
6
Reduced
13
Closed
7
Calls
$15K
Puts
–
Net Calls
+$15K
Net Calls Change
-$5K
Top Buyers
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$506K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$364K |
| 3 |
Two Sigma Advisers
New York
|
-$158K |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$134K |
| 5 |
Two Sigma Investments
New York
|
-$45.1K |
